#United States #Johnson & Johnson #MedTech #San Diego, California #AAOS 2025

Johnson & Johnson MedTech Showcases Digital Innovations in Orthopaedics

At the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) 2025 in San Diego, California, Johnson & Johnson MedTech, a leader in orthopaedic technologies, unveiled groundbreaking advancements in digital orthopaedics. With over 18 FDA 510(k) clearances and 45 global product launches in the past year alone, the company is reinforcing its commitment to innovation across numerous orthopaedic specialties including joint reconstruction and spinal surgery.

A Response to a Growing Global Need

With approximately 1.7 billion individuals worldwide living with musculoskeletal conditions—more than the combined prevalence of cancer, heart, and lung diseases—there is an urgent necessity for innovative orthopaedic solutions. Aldo Denti, Company Group Chairman of Orthopaedics at Johnson & Johnson MedTech emphasized this point, stating, "Our innovations are transforming the full ecosystem of orthopaedic procedures, meeting the rising demand for effective care."

Highlights of Innovations Introduced

1. VELYS™ Robotic-Assisted Solution: Already performing over 100,000 total knee replacements across 31 markets, this CT-free digital system enhances surgical precision and workflow for knee arthroplasty. Recently cleared by the FDA for unicompartmental knee arthroplasty, VELYS™ aids in overcoming alignment challenges while allowing surgeons to place implants accurately without CT imaging.

2. KINCISE™ 2 Surgical Automated System: Recognizing the physical demands placed on surgeons during hip and knee procedures, this next-generation power tool is designed to minimize strenuous motions, offering automation and customizable options.

3. VELYS™ Active Robotic Assistance: For spinal surgeries, Johnson & Johnson has developed the VELYS™ Spine system, which integrates navigation and advanced robotic technology, streamlining complex surgical workflows for spine surgeons.

4. VOLT™ Trauma System: This plating system, which presents a combination of dynamic compression and flexible angle locking, has not only received FDA clearance but has also been awarded the European CE Mark and is set for launch in select European markets.

5. INHANCE™ INTACT™ for Shoulder Replacement: This newly approved instrument set allows for a unique surgical approach that minimizes patient immobilization post-surgery, significantly improving recovery times.

6. Advance Case Management Powered by AI: This innovative system eases pre-surgical processes, driving efficiency in operating rooms through streamlined patient data management and scheduling, ultimately enhancing the patient experience.

7. Wound Closure and Healing: The integration of STRATAFIX™ and DERMABOND™ PRINEO™ systems has been demonstrated to provide benefits in both efficiency for surgeons and higher satisfaction for patients.

Commitment to Future of Healthcare

Johnson & Johnson MedTech's dedication to addressing the global magnitudes of musculoskeletal conditions emphasizes their ongoing commitment to healthcare innovation and user-centered design. They offer an extensive orthopaedic portfolio aimed at not just treating but restoring the movement for countless patients globally.

As healthcare continues to evolve, Johnson & Johnson MedTech aims to be at the forefront of providing holistic and effective surgical solutions. For those attending AAOS 2025, visit their booth for a firsthand look at these cutting-edge technologies that are truly redefining the landscape of digital orthopaedics. The mission remains clear: leveraging extensive expertise and cutting-edge technology to enhance surgical outcomes for millions.

For more information on these revolutionary advancements, follow Johnson & Johnson MedTech on their official social media channels and engage in the conversation around the future of orthopaedics and healthcare solutions.